Ornithine decarboxylase as an enzyme target for therapy
- PMID: 1438532
- DOI: 10.1016/0163-7258(92)90032-u
Ornithine decarboxylase as an enzyme target for therapy
Abstract
Interest in ornithine decarboxylase (ODC) and the therapeutic effects of its inhibition with the consequent depletion of polyamine biosynthesis has been widespread since the late 1970s and 1980s. This review covers new information about the properties of ODC, recent findings with ODC inhibitors and a discussion of the mechanism of inactivation of ODC by eflornithine. Recent in vivo therapeutic approaches of ODC inhibition are also discussed including: cancer and cancer chemoprevention; autoimmune diseases; polyamines and the blood-brain barrier, ischemia and hyperplasia; the NMDA receptor and modulation by polyamines; hearing loss; African trypanosomiasis; Pneumocystis carinii pneumonia and Cryptosporidium in AIDS; and other infectious diseases/organisms.
Similar articles
-
Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.Antimicrob Agents Chemother. 1994 Nov;38(11):2545-52. doi: 10.1128/AAC.38.11.2545. Antimicrob Agents Chemother. 1994. PMID: 7872745 Free PMC article.
-
Involvement of antizyme in stabilization of ornithine decarboxylase caused by inhibitors of polyamine synthesis.Eur J Biochem. 1989 Mar 1;180(1):181-4. doi: 10.1111/j.1432-1033.1989.tb14630.x. Eur J Biochem. 1989. PMID: 2495941
-
[DFMO: an alternative therapeutic agent for human African trypanosomiasis].Bull Soc Pathol Exot Filiales. 1988;81(3 Pt 2):571-7. Bull Soc Pathol Exot Filiales. 1988. PMID: 3143490 Review. French.
-
Structural insight into DFMO resistant ornithine decarboxylase from Entamoeba histolytica: an inkling to adaptive evolution.PLoS One. 2013;8(1):e53397. doi: 10.1371/journal.pone.0053397. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326423 Free PMC article.
-
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.Amino Acids. 2007 Aug;33(2):213-23. doi: 10.1007/s00726-007-0531-2. Epub 2007 Apr 19. Amino Acids. 2007. PMID: 17443268 Review.
Cited by
-
Identification of essential active-site residues in ornithine decarboxylase of Nicotiana glutinosa decarboxylating both L-ornithine and L-lysine.Biochem J. 2001 Dec 15;360(Pt 3):657-65. doi: 10.1042/0264-6021:3600657. Biochem J. 2001. PMID: 11736657 Free PMC article.
-
Minimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor.PLoS One. 2011;6(9):e24366. doi: 10.1371/journal.pone.0024366. Epub 2011 Sep 9. PLoS One. 2011. PMID: 21931692 Free PMC article.
-
Cloning of a trypanosomatid gene coding for an ornithine decarboxylase that is metabolically unstable even though it lacks the C-terminal degradation domain.Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):397-402. doi: 10.1073/pnas.94.2.397. Proc Natl Acad Sci U S A. 1997. PMID: 9012793 Free PMC article.
-
Regulation of a high-affinity diamine transport system in Trypanosoma cruzi epimastigotes.Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):481-6. doi: 10.1042/bj3160481. Biochem J. 1996. PMID: 8687391 Free PMC article.
-
Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma.Mol Cancer Ther. 2009 Jul;8(7):2067-75. doi: 10.1158/1535-7163.MCT-08-1217. Epub 2009 Jul 7. Mol Cancer Ther. 2009. PMID: 19584241 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
